Css LLC Grifols Sa Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $159,999 - $251,891	-9,828 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.57 - $23.52 $192,333 - $231,154	9,828 New	9,828 $229,000
Q3 2019 Nov 14, 2019	SELL	$19.85 - $22.76 $195,085 - $223,685	-9,828 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $172,874 - $207,370	9,828 New	9,828 $207,000
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $171,400 - $211,596	-9,828 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $197,247 - $215,134	9,828	9,828 $215,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.23B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.